Genmab A/S announced DARZALEX sales results for the first quarter of 2024. For the quarter, the company reported net sales of DARZALEX® in the first quarter of 2024 totaled USD 2,692 million. Net trade sales were USD 1,464 million in the U.S. and USD 1,228 million in the rest of the world.